How to interpret Cardlytics Inc (CDLX)’s stock chart patterns

While Cardlytics Inc has underperformed by -3.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CDLX rose by 10.18%, with highs and lows ranging from $19.57 to $2.57, whereas the simple moving average fell by -37.03% in the last 200 days.

On November 29, 2023, Lake Street started tracking Cardlytics Inc (NASDAQ: CDLX) recommending Buy.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Analysis of Cardlytics Inc (CDLX)

Further, the quarter-over-quarter increase in sales is 8.66%, showing a positive trend in the upcoming months.

In order to gain a clear picture of Cardlytics Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -102.29% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.15, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 746.64K can be a very valuable indicator of volatility for CDLX stock. On a monthly basis, the volatility of the stock is set at 6.57%, whereas on a weekly basis, it is put at 8.71%, with a loss of -5.90% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.33, showing growth from the present price of $6.06, which can serve as yet another indication of whether CDLX is worth investing in or should be passed over.

How Do You Analyze Cardlytics Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 7.21%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 71.48% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Are institutional investors increasing their holdings in CDLX shares?

The recent increase in stakes in CDLX appears to be a result of several institutional investors and hedge funds increasing their positions. CAS Investment Partners LLC’s position in CDLX has decreased by -1.00% in the first quarter. The company now owns 5,361,961 shares of the stock, with a value of $49.38 million, following the sale of -54,155 additional shares during the last quarter. BlackRock Fund Advisors made another decreased to its shares in CDLX during the first quarter, downing its stake by -1.56%. During the last quarter, the company picked up -36,335 additional shares for a total stake of worth $21.15 million, bringing number of shares owned by the company to 2,296,419.

During the first quarter, The Vanguard Group, Inc. added a 230,195 position in CDLX. 683 Capital Management LLC sold an additional -0.29 million shares in the last quarter, decreasing its holdings by -14.14%, now holding 1.76 million shares worth $16.21 million. CDLX shares are owned by institutional investors to the tune of 71.48% at present.

Related Posts